We are live on
!
Find out more
LCOV
London Company of Virginia Portfolio holdings
AUM
$16.2B
1-Year Est. Return
17.5%
This Fund
S&P 500
This Quarter
Est. Return
+8.11%
1 Year Est. Return
+17.5%
3 Year Est. Return
+53.53%
5 Year Est. Return
+68.8%
10 Year Est. Return
+271.54%
AUM
$12.9B
AUM Growth
+$617M
(+5%)
Cap. Flow
-$259M
Cap. Flow
% of AUM
-2.01%
Top 10 Holdings %
Top 10 Hldgs %
32.24%
Holding
140
New
5
Increased
24
Reduced
87
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$232M |
| 2 |
Martin Marietta Materials
MLM
|
+$72.4M |
| 3 |
PACCAR
PCAR
|
+$65.5M |
| 4 |
Entegris
ENTG
|
+$62.6M |
| 5 |
Skyworks Solutions
SWKS
|
+$24.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$145M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$69.4M |
| 3 |
Deere & Co
DE
|
+$30.5M |
| 4 |
Cintas
CTAS
|
+$29.7M |
| 5 |
Progressive
PGR
|
+$26.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.21% |
| 2 | Technology | 17.49% |
| 3 | Financials | 16.24% |
| 4 | Consumer Discretionary | 12.24% |
| 5 | Consumer Staples | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Adient
ADNT
$1.44B
| $14.6M | 0.11% |
371,710
-112,138
| -23% | -$5.05M |
|
102
Tredegar Corp
TG
$281M
| $11.8M | 0.09% |
543,371
-129,671
| -19% | -$2.97M |
|
103
Tejon Ranch
TRC
$441M
| $9.18M | 0.07% |
422,785
-87,558
| -17% | -$2M |
|
104
Olin
OLN
$2.13B
| $8.22M | 0.06% |
320,122
-72,938
| -19% | -$2.14M |
|
105
iShares Core S&P Mid-Cap ETF
IJH
$128B
| $4.69M | 0.04% |
116,525
+80,895
| +227% | +$3.25M |
|
106
iShares Russell 2000 ETF
IWM
$82.2B
| $4.54M | 0.04% |
26,961
+12,878
| +91% | +$2.17M |
|
107
iShares Core S&P 500 ETF
IVV
$904B
| $3.31M | 0.03% |
11,320
-46,556
| -80% | -$13.4M |
|
108
Berkshire Hathaway Class A
BRK.A
$1.09T
| $3.2M | 0.02% |
10
| – | – |
|
109
CSX Corp
CSX
$92.8B
| $2.79M | 0.02% |
112,977
| – | – |
|
110
Eli Lilly
LLY
$1.09T
| $2.1M | 0.02% |
19,575
+595
| +3% | +$59.5K |
|
111
ExxonMobil
XOM
$657B
| $1.62M | 0.01% |
19,052
| – | – |
|
112
Mondelez International
MDLZ
$79.4B
| $1.61M | 0.01% |
37,464
| – | – |
|
113
NVIDIA
NVDA
$5.43T
| $1.12M | 0.01% |
159,200
| – | – |
|
114
IBM
IBM
$222B
| $1.1M | 0.01% |
7,603
-32
| -0.4% | -$4.47K |
|
|
GLDD
115
DELISTED
Great Lakes Dredge & Dock
GLDD
| $929K | 0.01% |
+149,800
| New | +$835K |
|
116
British American Tobacco
BTI
$120B
| $715K | 0.01% |
15,336
-2,622
| -15% | -$133K |
|
117
Hershey
HSY
$37B
| $699K | 0.01% |
6,852
-1,885
| -22% | -$186K |
|
118
Amazon
AMZN
$2.88T
| $641K | 0.01% |
6,400
| – | – |
|
119
Netflix
NFLX
$309B
| $602K | ﹤0.01% |
16,100
| – | – |
|
120
Sherwin-Williams
SHW
$87.4B
| $592K | ﹤0.01% |
3,900
| – | – |
|
121
Towne Bank
TOWN
$3.49B
| $505K | ﹤0.01% |
16,369
| – | – |
|
122
Accenture
ACN
$110B
| $499K | ﹤0.01% |
2,933
| – | – |
|
|
RTN
123
DELISTED
Raytheon Company
RTN
| $478K | ﹤0.01% |
2,315
-1,360
| -37% | -$271K |
|
124
C.H. Robinson
CHRW
$17.1B
| $448K | ﹤0.01% |
4,580
| – | – |
|
125
Robert Half
RHI
$4.25B
| $429K | ﹤0.01% |
6,100
| – | – |
|
Similar funds
UCFA
IG
EIP
MG
CLGM
LCIP
EF
London Company of Virginia's Q3 2018 Portfolio in Review
As of Q3 2018, London Company of Virginia held 140 positions worth $12.9B, up 5% from $12.2B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
London Company of Virginia's Q3 2018 filing shows 5 new, 24 increased, 87 reduced and 4 closed positions. Its largest new stake was Entegris: 1,860,389 shares worth $53.9M. The largest sale was Target, an estimated $145M.
By sector, the portfolio is most concentrated in Industrials at 19% of assets, up from 19% a quarter earlier, followed by Technology and Financials.
- London Company of Virginia's largest Q3 2018 buy was Entegris: 1,860,389 shares worth $53.9M.
- London Company of Virginia added most to Johnson & Johnson in Q3 2018, an estimated $232M increase.
- London Company of Virginia's biggest Q3 2018 reduction was Target, cutting an estimated $145M.
- London Company of Virginia fully exited Alexion Pharmaceuticals in Q3 2018, selling an estimated $69.4M.
- London Company of Virginia's ten largest holdings make up 32% of its $12.9B portfolio in Q3 2018.
- London Company of Virginia opened 5 new positions and closed 4 in Q3 2018.
- London Company of Virginia's portfolio value rose 5% quarter-over-quarter to $12.9B.
Based on London Company of Virginia's 13F filing for Q3 2018, filed 14 Nov 2018.